查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446554

髂动脉支架市场规模、份额、趋势分析报告：按类型、按动脉病变、按最终用途、按地区、按细分市场、预测，2024-2030 年

Iliac Stent Market Size, Share & Trends Analysis Report By Type (Self-expandable Stents, Balloon-expandable Stents), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

髂动脉支架市场成长与趋势：

Grand View Research, Inc最新报告显示，到2030年，全球髂支架市场规模预计将达到15.3亿美元，预计2024年至2030年复合年增长率为5.8%。

由于周边动脉疾病盛行率的增加、医疗技术的不断进步以及人们对微创手术作为心血管疾病有效治疗选择的认识不断增强等因素，该市场预计将增长。

该行业的成长是由新产品开发和增加的通畅性调整程序所推动的。例如，自动扩张型支架在治疗髂外动脉方面已显示出优异的效果。此外，周边动脉疾病（PAD）盛行率的增加预计将推动髂支架市场的成长。根据健康指标与评估研究所 2023 年 10 月的一篇报导，全球 PAD 盛行率为 1.52%，约 1.13 亿人。此外，2022 年 NCBI 的一篇论文预测，PAD 的年发生率将接近 1,000 万人。

髂支架主要参与者之间不断增加的策略性倡议预计将推动成长。例如，2024年1月，Zylox-Tonbridge医疗科技有限公司的周边静脉支架系统获得国家药品监督管理局（NMPA）的上市核准。此外，2023 年 10 月，Getinge AB 宣布用于治疗髂动脉阻塞性疾病的 iCast 覆膜支架系统在美国上市。

髂动脉支架市场报告亮点

  • 医疗保健产业的髂支架市场预计到2023年将达到10.3亿美元，预计2030年将达到15.3亿美元。
  • 预计2024年至2030年，髂骨支架市场将以5.8%的年复合成长率成长，2030年将达到15.3亿美元。
  • 2023年，北美占据髂支架市场最大份额，销售份额为43.7%。美国易患 PAD 的老年人口的增加预计将增加对支架置入术的需求，并在预测期内显着促进市场成长。
  • 按支架类型划分，自动扩张型支架在 2023 年占据最大的销售份额，达到 60.4%，因为这些支架的积极的长期临床试验结果预计将为医疗保健提供者提供信心。这是有原因的。
  • 按动脉病变分，2023年髂总动脉病变细分市场销售份额最大，为60.5%。由于患有高胆固醇和肥胖症的患者数量不断增加，预计对髂支架的需求将会增加。
  • 以最终用途计算，到 2023 年，医院细分市场将占销售额的压倒性 61.7%。该医院作为转诊中心，患者接受综合治疗，包括诊断影像、医疗管理和介入手术（如髂骨支架置入术）。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 Ilial 支架市场：变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 髂动脉支架市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 髂动脉支架市场：类型估算与趋势分析

  • 髂动脉支架市场：型式仪表板
  • 髂动脉支架市场：类型变化分析
  • 髂动脉支架市场规模（按类型）、预测和趋势分析，2018-2030 年
  • 自动扩张型支架
  • 球囊扩张型支架
  • 其他的

第五章 髂动脉支架市场：动脉病变预估及趋势分析

  • 髂动脉支架市场：动脉病变仪表板
  • 髂动脉支架市场：动脉病变的变化分析
  • 髂动脉支架市场规模（按动脉病变）、预测和趋势分析，2018-2030 年
  • 髂总动脉病变
  • 钙化病变
  • 完全阻塞性病变

第六章髂动脉支架市场：最终用途估计与趋势分析

  • 髂动脉支架市场：最终用途仪表板
  • 髂动脉支架市场：最终用途变化分析
  • 髂动脉支架市场规模（按最终用途、预测和趋势分析），2018-2030 年
  • 医院
  • 门诊设施
  • 其他的

第 7 章 髂动脉支架市场：区域估计和趋势分析，按国家、按类型、按动脉病变、按最终用途

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • BD
    • Abbott
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • Cook
    • Medtronic
    • Vascular
    • Terumo Corporation
    • Getinge AB
    • Biotronik SE &Co KG
Product Code: GVR-4-68040-206-4

Iliac Stent Market Growth & Trends:

The globall iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030, based on a new report by Grand View Research, Inc. The market is expected to grow due to factors such as the increasing prevalence of peripheral artery diseases, growing advancements in medical technology, and expanding awareness about minimally invasive procedures as an effective treatment option for cardiovascular diseases.

The industry's growth is driven by new product development and aligned procedures with enhanced patency. For instance, self-expanding stents have demonstrated exceptional results in the treatment of external iliac artery. Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth. According to an article by the Institute for Health Metrics and Evaluation in October 2023, the global prevalence of PAD was pegged at 1.52% or nearly 113 million people. Additionally, NCBI's article in 2022 projected the annual incidence of PAD to be nearly 10 million.

An increase in strategic initiatives amongst the key players of iliac stents is anticipated to propel growth. For instance, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Administration (NMPA) for its peripheral venous stent system. Furthermore, in October 2023, Getinge AB announced the commercial availability of its product, iCast covered stent system to treat iliac arterial occlusive disease in the U.S.

Iliac Stents Market Report Highlights:

  • The iliac stents marketin the healthcare industry was estimated at USD 1.03 Billion in 2023 and is expected to reach USD 1.53 Billion in 2030
  • The iliac stents marketis expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 to reach USD 1.53 Billion by 2030
  • In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%. The growing geriatric population in the U.S., which is susceptible to PAD is expected to increase the demand for stenting procedures, thereby significantly contributing to the market growth over the forecast period
  • By type, self-expandable stents segment accounted for the largest revenue share of 60.4% in 2023driven by favorable long-term clinical study results for these stents that are expected to instill confidence in healthcare providers
  • By artery lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023 driven by growing cases of patients suffering from high cholesterol and obesity are expected to boost the demand for iliac stents, as these conditions cause plaque buildup, which narrows or blocks artery lumen
  • By end use, hospital segment accounted for a dominant revenue share of 61.7% in 2023. Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Artery lesions
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for Primary Interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Parent market analysis (Model 2)
    • 1.7.4. Approach 2: Parent market analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Artery lesions outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Iliac Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of peripheral artery disease (PAD)
      • 3.2.1.2. Technological advancements in iliac stents
      • 3.2.1.3. Increasing number of product approvals in developed and developing countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of reimbursement policies for venous stenting
      • 3.2.2.2. Product recalls
  • 3.3. Iliac Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Iliac Stents Market: Type Estimates & Trend Analysis

  • 4.1. Iliac Stent Market: Type Dashboard
  • 4.2. Iliac Stent Market: Type Movement Analysis
  • 4.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Self-Expandable Stents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Balloon-Expandable Stents
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Iliac Stents Market: Artery Lesions Estimates & Trend Analysis

  • 5.1. Iliac Stent Market: Artery Lesions Dashboard
  • 5.2. Iliac Stent Market: Artery Lesions Movement Analysis
  • 5.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Artery Lesion, 2018 to 2030 (USD Million)
  • 5.4. Common Iliac Artery Lesions
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Severe Calcified Lesions
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Complete Obstructive Lesions
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Iliac Stents Market: End-Use Estimates & Trend Analysis

  • 6.1. Iliac Stent Market: End-Use Dashboard
  • 6.2. Iliac Stent Market: End-Use Movement Analysis
  • 6.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Iliac Stents Market: Regional Estimates & Trend Analysis by Country, Type, Artery Lesions, & End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa Market Estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Boston Scientific Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. W. L. Gore & Associates, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cook
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Medtronic
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Vascular
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Getinge AB
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Biotronik SE & Co KG
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 5 North America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 8 U.S. Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 11 Canada Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 15 Europe Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 18 Germany Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 21 UK Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 24 France Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 27 Italy Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 30 Spain Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 33 Denmark Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 36 Sweden Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 39 Norway Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 45 China Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 46 China Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 49 Japan Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 51 India Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 52 India Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 55 South Korea Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 58 Australia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 61 Thailand Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 65 Latin America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 68 Brazil Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 71 Mexico Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 74 Argentina Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 76 MEA Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 78 MEA Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 81 South Africa Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 87 UAE Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Iliac Stents market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Iliac Stents Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and artery lesions segment snapshot
  • Fig. 10 End-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Prevalence of PAD in 2022, by WHO regions
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Iliac Stents market: Type outlook and key takeaways
  • Fig. 17 Iliac Stents market: Type movement analysis
  • Fig. 18 Self-expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Balloon expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Iliac Stents market: Artery Lesions outlook and key takeaways
  • Fig. 22 Iliac Stents market: Artery Lesions movement analysis
  • Fig. 23 Common Iliac Artery Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Severe Calcified Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Complete Obstructive Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Iliac Stents market: End-use outlook and key takeaways
  • Fig. 27 Iliac Stents market: End-use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Outpatient Facilities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Iliac Stents market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways (1/2)
  • Fig. 33 Regional marketplace: Key takeaways (2/2)
  • Fig. 34 North America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Rest of Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Reimbursement scenario
  • Fig. 60 Japan Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Regulatory framework
  • Fig. 63 Reimbursement scenario
  • Fig. 64 China Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Reimbursement scenario
  • Fig. 67 India Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Australia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Korea Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Malaysia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Vietnam Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Philippines Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Brazil regulation details
  • Fig. 84 Reimbursement scenario
  • Fig. 85 Brazil Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina pharmaceuticals registration details
  • Fig. 88 Argentina Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Regulatory framework
  • Fig. 91 Reimbursement scenario
  • Fig. 92 Mexico Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Rest of Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Saudi Arabia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UAE Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Kuwait Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Rest of MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Company market share analysis, 2023
  • Fig. 106 Strategic Framework